House Wary Of Reopening Medicare Rx Legislation, Staffer Says
This article was originally published in The Pink Sheet Daily
Executive Summary
The House will focus on helping CMS implement the bill, House Republican staffer Canfield says. Reopening the bill to make changes could result in “mischief,” but a technical corrections bill may be needed, she notes.
You may also be interested in...
Senate Rx Import Bill Will Add Stronger Anti-Counterfeit Provisions In 2005
When Health Committee Chairman Judd Gregg (R-N.H.) reintroduces his drug importation bill, it will include requirements for full drug "pedigrees" on imported drugs. Legislation could also set up requirements for pedigrees on domestic drugs.
U.S. Patents Could Limit President's AIDS Drug Assistance Plan, GAO Says
The U.S. Global AIDS Coordinator's Office suggests it will use its authority to purchase an FDA-approved generic antiretroviral product for which permission could not be obtained from the patent holder. FDA grants tentative approval to a South African firm for a generic co-packaged version of Combivir and Viramune.
Sanofi-Aventis' Once-Daily Allegra-D To Launch Mid-Year
With the exception of Allegra, the company's "top 15" products produced double-digit sales growth in 2004. The fastest growing products include the long-acting insulin Lantus (up 80%), the osteoporosis agent Actonel (up 60%) and the oncologic Eloxatin (up 57%).